Data / Form D filings / Spinifex Pharmaceuticals Inc
Spinifex Pharmaceuticals Inc: Form D filing
Spinifex Pharmaceuticals Inc, a pharmaceuticals company in Stamford, United States, filed a Form D with the SEC in 2014. The latest, on May 7, 2014, reports $6.2 million sold of a $16 million offering to 1 investor.
Find out what Spinifex Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- ONE STAMFORD PLAZA, 263 TRESSER BOULEVARD, 9TH FLOOR, Stamford, United States, 06901
- Phone
- (203) 564-1552
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1607267
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 7, 2014 | New notice | $16,000,000 | $6,168,383 | $9,831,617 | 1 | Apr 23, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tom McCarthy | Executive Officer, Director, Promoter | |
| Christopher Nave | Director | |
| Heath Lukatch | Director | |
| Brent Ahrens | Director | |
| Stephen Collins | Director | |
| Joshua Funder | Director | |
| Declan Doogan | Director |
Every Form D from the week of May 5, 2014 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Spinifex Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.